Tomas Valdivia - 14 Dec 2021 Form 4 Insider Report for Bright Health Group Inc. (NEUE)

Reporting relationship
CHIEF HEALTH & EQUITY OFFICER
Issuer ticker
NEUE
Reported as of
14 Dec 2021
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
16 Dec 2021, 18:36:54 UTC
Prior SEC filing
24 Jun 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Eric Halverson for Tomas Valdivia, Attorney-in-Fact

Key filing fact

Tomas Valdivia filed Form 4 for Bright Health Group Inc. (NEUE) on 16 Dec 2021.

Key facts

  • This page summarizes Tomas Valdivia's Form 4 filing for Bright Health Group Inc. (NEUE).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 16 Dec 2021, 18:36.

Change

  • Previous filing in this sequence was filed on 24 Jun 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BHG transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+500,000
Change %
Price
$0.000000
Shares after
500,000
Date
14 Dec 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
500,000
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of BHG common stock.

Footnote F2

The restricted stock units vest 60% on the 2nd anniversary of the grant date and 40% on the 3rd anniversary of the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .